Møller, Morten HChew, Michelle SOlkkola, Klaus TRehn, MariusYli-Hankala, ArviSigurðsson, Martin Ingi2025-11-202025-11-202022-02-28Møller, M H, Chew, M S, Olkkola, K T, Rehn, M, Yli-Hankala, A & Sigurðsson, M I 2022, 'Therapeutics and COVID-19-A living WHO guideline : Endorsement by the Scandinavian Society of Anaesthesiology and Intensive Care Medicine', Acta Anaesthesiologica Scandinavica, vol. 66, no. 5, pp. 636-637. https://doi.org/10.1111/aas.140460001-51724835612038a07989-6a8a-4243-acd9-1d96757a7d1335170027unpaywall: 10.1111/aas.1404685125900433https://hdl.handle.net/20.500.11815/6683Funding Information: Funding was provided from the Scandinavian Society of Anaesthesiology and Intensive Care Medicine and institutional and/or departmental sources. Publisher Copyright: © 2022 The Authors. Acta Anaesthesiologica Scandinavica published by John Wiley & Sons Ltd on behalf of Acta Anaesthesiologica Scandinavica Foundation.The Clinical Practice Committee of the Scandinavian Society of Anaesthesiology and Intensive Care Medicine endorses the Living WHO guideline on therapeutics and COVID-19. This trustworthy continuously updated guideline serves as a highly useful decision aid for Nordic anaesthesiologists caring for patients with COVID-19.2366299636-637eninfo:eu-repo/semantics/openAccessAnesthesiologyCOVID-19Critical CareHumansSocieties, MedicalWorld Health OrganizationtherapeuticsAGREE IIclinical practice guidelineWHOAnesthesiology and Pain MedicineSDG 3 - Good Health and Well-being/dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/article10.1111/aas.14046